Approximately 30 million people worldwide suffer from familial hypercholesterolaemia. These patients have an increased risk of atherosclerotic cardiovascular disease and its atherothrombotic complications already in middle age. It is likely that COVID-19 further increases their cardiovascular risk, both during infection and after recovery. We advise continued use of treatment for the severe hypercholesterolaemia observed in these patients. ... More
Due to health risks relating to the spread of the coronavirus disease (COVID-19), the 88th EAS Congress in Geneva, Switzerland has been postponed. The new planned date of the congress is October 4 – 7, 2020.